Compare OABI & AVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OABI | AVBC |
|---|---|---|
| Founded | 2012 | 1869 |
| Country | United States | United States |
| Employees | 89 | 241 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 391.4M | 380.1M |
| IPO Year | N/A | N/A |
| Metric | OABI | AVBC |
|---|---|---|
| Price | $2.11 | $20.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.50 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 576.9K | 50.3K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $52.42 | N/A |
| Revenue Next Year | $64.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.32 | $14.23 |
| 52 Week High | $2.79 | $21.43 |
| Indicator | OABI | AVBC |
|---|---|---|
| Relative Strength Index (RSI) | 44.44 | 54.98 |
| Support Level | $1.75 | $19.75 |
| Resistance Level | $2.13 | $21.35 |
| Average True Range (ATR) | 0.18 | 0.48 |
| MACD | -0.09 | 0.12 |
| Stochastic Oscillator | 11.04 | 66.41 |
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Avidia Bancorp Inc business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial and industrial loans, one-to four-family residential mortgage loans, and commercial real estate loans.